OA10352A - Combination of atovaquone with proguanil for the treatment of protozoal infections - Google Patents
Combination of atovaquone with proguanil for the treatment of protozoal infections Download PDFInfo
- Publication number
- OA10352A OA10352A OA60668A OA60668A OA10352A OA 10352 A OA10352 A OA 10352A OA 60668 A OA60668 A OA 60668A OA 60668 A OA60668 A OA 60668A OA 10352 A OA10352 A OA 10352A
- Authority
- OA
- OAPI
- Prior art keywords
- proguanil
- naphthoquinone
- atovaquone
- hydroxy
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929224739A GB9224739D0 (en) | 1992-11-26 | 1992-11-26 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
OA10352A true OA10352A (en) | 2001-10-22 |
Family
ID=10725687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA60668A OA10352A (en) | 1992-11-26 | 1995-05-26 | Combination of atovaquone with proguanil for the treatment of protozoal infections |
Country Status (38)
Country | Link |
---|---|
US (3) | US5998449A (ja) |
EP (1) | EP0670719B1 (ja) |
JP (1) | JP3768231B2 (ja) |
KR (1) | KR100294802B1 (ja) |
CN (1) | CN1087935C (ja) |
AP (1) | AP517A (ja) |
AT (1) | ATE191340T1 (ja) |
AU (1) | AU685408B2 (ja) |
BG (1) | BG62595B1 (ja) |
CA (1) | CA2150234E (ja) |
CY (1) | CY2193B1 (ja) |
CZ (2) | CZ289171B6 (ja) |
DE (1) | DE69328307T2 (ja) |
DK (1) | DK0670719T3 (ja) |
ES (1) | ES2145114T3 (ja) |
GB (1) | GB9224739D0 (ja) |
GR (1) | GR3033745T3 (ja) |
HK (1) | HK1004468A1 (ja) |
HU (1) | HU225918B1 (ja) |
IL (1) | IL107755A (ja) |
MX (1) | MX9307402A (ja) |
MY (1) | MY114241A (ja) |
NO (1) | NO313225B1 (ja) |
NZ (1) | NZ257901A (ja) |
OA (1) | OA10352A (ja) |
PE (1) | PE55694A1 (ja) |
PL (1) | PL174323B1 (ja) |
PT (1) | PT670719E (ja) |
RO (1) | RO119280B1 (ja) |
RU (1) | RU2108092C1 (ja) |
SA (1) | SA93140434B1 (ja) |
SG (1) | SG45387A1 (ja) |
SI (1) | SI9300614A (ja) |
SK (1) | SK281559B6 (ja) |
TW (1) | TW253835B (ja) |
UA (1) | UA45948C2 (ja) |
WO (1) | WO1994012164A1 (ja) |
ZA (1) | ZA938832B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9424013D0 (en) * | 1994-11-29 | 1995-01-18 | Wellcome Found | Medicaments |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
GB9822681D0 (en) * | 1998-10-16 | 1998-12-09 | Vitabiotics Ltd | Method of treatment |
AU758167B2 (en) | 1999-04-09 | 2003-03-20 | Glaxo Group Limited | Combination preparation for treating malaria |
US7104076B2 (en) * | 2004-06-24 | 2006-09-12 | Carrier Corporation | Lubricant return schemes for use in refrigerant cycle |
ITMI20070941A1 (it) * | 2007-05-09 | 2008-11-10 | Chimico Internazi0Nale S P A L | Procedimento per la preparazione di naftochinoni trans2,3-disostituiti |
WO2011021230A2 (en) * | 2009-08-20 | 2011-02-24 | Ipca Laboratories Limited | Novel complex for treatment and/or prophylaxis of parasitic infections |
US20180055835A1 (en) | 2016-08-25 | 2018-03-01 | Immune Therapeutics Inc. | Method for Treating And Preventing Protozoal Infections |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2533648A (en) * | 1949-03-05 | 1950-12-12 | Joseph H Warburg | Circular saw making |
NL6411993A (ja) * | 1963-10-18 | 1965-04-20 | ||
US3347830A (en) * | 1964-07-30 | 1967-10-17 | Grace W R & Co | Process of polymerizing formaldehyde |
GB1141735A (en) * | 1966-11-23 | 1969-01-29 | Pfizer & Co C | Pharmaceutical anti-tumor composition |
NL6817526A (ja) * | 1968-01-24 | 1969-07-28 | ||
US3655699A (en) * | 1970-03-02 | 1972-04-11 | Pfizer | Analogues of lapachol as antitumor agents |
DE2601458A1 (de) * | 1975-01-20 | 1976-07-22 | Ciba Geigy Ag | Loesliche, von phenylindandiaminen abgeleitete polyamide |
ZA786551B (en) * | 1977-11-22 | 1980-07-30 | Wellcome Found | Antitheilerial naphthoquinone derivatives |
US4485117A (en) * | 1981-10-16 | 1984-11-27 | Hudson Alan T | Antiprotozoal compounds |
US4485116A (en) * | 1981-10-16 | 1984-11-27 | Hudson Alan T | Antiprotozoal compounds |
US5053432A (en) * | 1983-04-14 | 1991-10-01 | Burroughs Wellcome Co. | Naphthoquinone derivatives |
GB8310141D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Naphthoquinone derivatives |
GB8310140D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Antiprotozoal agents |
JPS59196467A (ja) * | 1983-04-23 | 1984-11-07 | Nissan Motor Co Ltd | 車輪速及びまたは車輪加減速度検出方法 |
SG23618G (en) * | 1988-08-16 | 1995-09-18 | Wellcome Found | Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections |
US5206268A (en) * | 1988-08-16 | 1993-04-27 | Burroughs Wellcome Co. | Medicaments |
US5225184A (en) * | 1988-08-16 | 1993-07-06 | Burroughs Wellcome Co. | Medicaments |
GB8819477D0 (en) * | 1988-08-16 | 1988-09-21 | Wellcome Found | Medicaments |
GB8921516D0 (en) * | 1989-09-22 | 1989-11-08 | Wellcome Found | Medicaments |
GB8923254D0 (en) * | 1989-10-16 | 1989-12-06 | Wellcome Found | Medicaments |
US5014737A (en) * | 1989-11-13 | 1991-05-14 | Allan Berman | Quartz integrated trough/sump recirculating filtered high-purity chemical bath |
GB9121316D0 (en) * | 1991-10-09 | 1991-11-20 | Wellcome Found | Heterocyclic compounds |
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9226905D0 (en) * | 1992-12-24 | 1993-02-17 | Wellcome Found | Pharmaceutical preparation |
US5529994A (en) * | 1993-05-05 | 1996-06-25 | Palo Alto Medical Foundation | Treatment for toxoplasmosis |
DK0648121T3 (ja) * | 1993-05-05 | 1997-02-24 | Palo Alto Medical Found | |
US5733932A (en) * | 1995-01-06 | 1998-03-31 | The Picower Institute For Medical Research | Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
US5747476A (en) * | 1996-07-17 | 1998-05-05 | Mortar & Pestle Veterinary Pharmacy, Inc. | Treatment of equine protozoal myeloencephalitis |
ZA983331B (en) * | 1997-05-01 | 1998-10-27 | Allegheny University Of The He | Method for treating protozoal infections |
AUPO821097A0 (en) * | 1997-07-25 | 1997-08-14 | Cultor Ltd. | A prophylactic |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
AU758167B2 (en) * | 1999-04-09 | 2003-03-20 | Glaxo Group Limited | Combination preparation for treating malaria |
-
1992
- 1992-11-26 GB GB929224739A patent/GB9224739D0/en active Pending
-
1993
- 1993-11-25 CZ CZ19951192A patent/CZ289171B6/cs not_active IP Right Cessation
- 1993-11-25 NZ NZ257901A patent/NZ257901A/en not_active IP Right Cessation
- 1993-11-25 UA UA95058430A patent/UA45948C2/uk unknown
- 1993-11-25 SI SI9300614A patent/SI9300614A/sl unknown
- 1993-11-25 EP EP94900254A patent/EP0670719B1/en not_active Expired - Lifetime
- 1993-11-25 RO RO95-00963A patent/RO119280B1/ro unknown
- 1993-11-25 DE DE69328307T patent/DE69328307T2/de not_active Expired - Lifetime
- 1993-11-25 PE PE1993231837A patent/PE55694A1/es not_active IP Right Cessation
- 1993-11-25 AU AU55322/94A patent/AU685408B2/en not_active Expired
- 1993-11-25 ZA ZA938832A patent/ZA938832B/xx unknown
- 1993-11-25 HU HU9501537A patent/HU225918B1/hu unknown
- 1993-11-25 IL IL10775593A patent/IL107755A/xx not_active IP Right Cessation
- 1993-11-25 CA CA002150234A patent/CA2150234E/en not_active Expired - Lifetime
- 1993-11-25 WO PCT/GB1993/002425 patent/WO1994012164A1/en active IP Right Grant
- 1993-11-25 RU RU95113501A patent/RU2108092C1/ru active
- 1993-11-25 PL PL93309222A patent/PL174323B1/pl unknown
- 1993-11-25 MY MYPI93002479A patent/MY114241A/en unknown
- 1993-11-25 KR KR1019950702071A patent/KR100294802B1/ko not_active IP Right Cessation
- 1993-11-25 CN CN93114723A patent/CN1087935C/zh not_active Expired - Lifetime
- 1993-11-25 PT PT94900254T patent/PT670719E/pt unknown
- 1993-11-25 DK DK94900254T patent/DK0670719T3/da active
- 1993-11-25 SK SK570-95A patent/SK281559B6/sk not_active IP Right Cessation
- 1993-11-25 AP APAP/P/1993/000592A patent/AP517A/en active
- 1993-11-25 SG SG1996005505A patent/SG45387A1/en unknown
- 1993-11-25 ES ES94900254T patent/ES2145114T3/es not_active Expired - Lifetime
- 1993-11-25 MX MX9307402A patent/MX9307402A/es unknown
- 1993-11-25 TW TW082109940A patent/TW253835B/zh not_active IP Right Cessation
- 1993-11-25 JP JP51291494A patent/JP3768231B2/ja not_active Expired - Lifetime
- 1993-11-25 AT AT94900254T patent/ATE191340T1/de active
- 1993-12-22 SA SA93140434A patent/SA93140434B1/ar unknown
-
1995
- 1995-05-19 NO NO19951995A patent/NO313225B1/no not_active IP Right Cessation
- 1995-05-22 BG BG99656A patent/BG62595B1/bg unknown
- 1995-05-26 OA OA60668A patent/OA10352A/en unknown
-
1997
- 1997-10-31 US US08/962,273 patent/US5998449A/en not_active Expired - Lifetime
-
1998
- 1998-04-23 HK HK98103412A patent/HK1004468A1/xx not_active IP Right Cessation
-
1999
- 1999-03-09 CZ CZ1999805A patent/CZ289692B6/cs not_active IP Right Cessation
- 1999-10-01 US US09/409,871 patent/US6166046A/en not_active Expired - Lifetime
-
2000
- 2000-06-22 GR GR20000401440T patent/GR3033745T3/el unknown
- 2000-08-29 CY CY0000044A patent/CY2193B1/xx unknown
- 2000-10-04 US US09/678,485 patent/US6291488B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0123239B1 (en) | Improvements in or relating to antiprotozoal agents | |
OA10352A (en) | Combination of atovaquone with proguanil for the treatment of protozoal infections | |
HU201672B (en) | Process for producing pharmaceutical compositions comprising podophyllotoxin | |
US5134168A (en) | Phenoxy and phenylthio, amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections | |
EP0572615B1 (en) | Medicament for the Treatment of Protozoal Infections caused by Babesia | |
EP0445141B1 (en) | Medicaments for the treatment of toxoplasmosis | |
WO1994003163A1 (en) | Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer | |
WO2015001799A1 (ja) | バベシア症の治療剤及び予防剤 | |
CZ242994A3 (en) | 1,4-naphthoquinone derivatives exhibiting anti-protozoic and anti-parasitic activity | |
JPH10509722A (ja) | Pneumocystis carinii感染の治療におけるリファブチンの使用およびリファブチンとアトバクオンとの組み合わせ |